SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Direct to consumer advertising in pharmaceutical markets
14 references·0 citing·43 second hop
Direct to consumer advertising in pharmaceutical markets (2005)Direct to consumer advertising in pharmac…Do Pharmaceutical Sales Respond to Scientific Evidence? (2002)Do Pharmaceutical Sales Respo…Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales (2002)Deregulating Direct‐to‐Consum…Moral hazard in physician prescription behavior (2000)Moral hazard in physician pre…Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Barriers to entry, brand adve…Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs (1999)Advertising and Competition i…Strategic Pricing of New Pharmaceuticals (1998)Strategic Pricing of New Phar…Information, marketing, and pricing in the U.S. antiulcer drug market. (1995)Information, marketing, and p…The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry (1994)The Roles of Marketing, Produ…Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Brand Loyalty, Entry, and Pri…COMPETITION AND THE CIGARETTE TV ADVERTISING BAN (1991)COMPETITION AND THE CIGARETTE…Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)Persuasion or Information? Pr…The Fat-Cat Effect, the Puppy-Dog Ploy, and the Lean and Hungry Look (1984)The Fat-Cat Effect, the Puppy…Informative Advertising with Differentiated Products (1984)Informative Advertising with …Equilibrium Distributions of Sales and Advertising Prices (1977)Equilibrium Distributions of …Limit Pricing and Entry under Incomplete Information: An Equilibrium Analysis (1982)Preemptive Patenting and the Persistence of Monopoly (1982)Incentives to Form Coalitions with Bertrand Competition (1985)A Theory of Dynamic Oligopoly, II: Price Competition, Kinked Demand Curves, and Edgeworth Cycles (1988)Quantity precommitment and Bertrand competition yield Cournot outcomes (1989)Pass-Through as an Economic Tool: Principles of Incidence under Imperfect Competition (2013)Econometric Measurement of the Duration of Advertising Effect on Sales (1976)Optimal Advertising and Optimal Quality (1976)Product differentiation advantages of pioneering brands (1980)Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011)Industrial Market Structure and Economic Performance. (1971)Generic Entry and the Pricing of Pharmaceuticals (1997)Uncertainty and Learning in Pharmaceutical Demand (2005)Killer Acquisitions (2020)Optimal Advertising Policy Under Dynamic Conditions (1976)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Diffusion of new pharmaceutical drugs in developing and developed nations (2004)Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)A New Product Growth for Model Consumer Durables (1969)A New Product Growth Model for Consumer Durables (1976)Health Care Financing Review (1980)Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)The Economics of Follow-on Drug Research and Development (2004)The Pharmaceutical Industry (2013)The economics of advertising (1972)Market Share Rewards to Pioneering Brands: An Empirical Analysis and Strategic Implications (1986)The Adoption of Innovations by Provider Organizations in Health Care (2007)Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field (2009)Economic Welfare and the Allocation of Resources for Invention (1962)An empirical model of learning and patient spillovers in new drug entry (2003)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists (2013)Entry, Capacity, Investment and Oligopolistic Pricing (1977)The Role of Investment in Entry-Deterrence (1980)Entry and Competition in Concentrated Markets (1991)Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration (2010)Looking into the Black Box: A Survey of the Matching FunctionOn the Efficiency of Matching and Related Models of Search and Unemployment (1990)Micro-Foundations of Urban Agglomeration Economies (2003)Electoral Competition and Special Interest Politics (1996)Distance, Lending Relationships, and Competition (2005)The Economics of Privacy (2016)
this work references cited by second hop

References

  • 1977Equilibrium Distributions of Sales and Advertising Prices1,034 cited
  • 1984The Fat-Cat Effect, the Puppy-Dog Ploy, and the Lean and Hungry Look873 cited
  • 1984Informative Advertising with Differentiated Products730 cited
  • 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
  • 1988Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals254 cited
  • 1998Strategic Pricing of New Pharmaceuticals249 cited
  • 2000Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry226 cited
  • 2002Do Pharmaceutical Sales Respond to Scientific Evidence?198 cited
  • 1995Information, marketing, and pricing in the U.S. antiulcer drug market.191 cited
  • 1999Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs176 cited
  • 2000Moral hazard in physician prescription behavior164 cited
  • 1994The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry111 cited
  • 2002Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales91 cited
  • 1991COMPETITION AND THE CIGARETTE TV ADVERTISING BAN90 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

No citing works inside the corpus for this window.